EUVIMEDEUVIMED entdecken
Multizentrische Studie

Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study

Sophie J M Reijers, Emma Davies, Dirk J Grünhagen, Marco Fiore, Charles Honore, Marco Rastrelli, Nikolaos Vassos, Lars E Podleska, Maya Niethard, Jens Jakob, Andraz Perhavec, Carlos Duarte und 21 weitere

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.112949 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Sophie J M Reijers und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: s.reijers@nk…. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms, Sarcoma, Kaposi. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The aim of this study was to investigate the response rates of different extremity soft-tissue sarcoma subtypes (eSTS) after isolated limb perfusion (ILP), based on an international multi-centre study. MATERIALS AND METHODS: The retrospective cohort comprised eSTS patients from 17 specialised ILP centres that underwent melphalan-based ILP, with or without recombinant human tumour necrosis factor (rhTNFα) (TM-ILP and M-ILP, respectively). Response was measured on imaging (magnetic resonance imaging) and/or clinical response, for which M-ILPs were excluded. RESULTS: A total of 1109 eSTS patients were included. The three most common histological subtypes were undifferentiated pleomorphic sarcoma (17%, n = 184), synovial sarcoma (16%, n = 175) and myxofibrosarcoma (8%, n = 87). rhTNFα was used in 93% (TM-ILP) and resulted in a significantly better overall response rate (ORR, p = 0.031) and complete responses (CR, p < 0.001) in comparison to M-ILP, without significant differences among histological subgroups. The ORR of TM-ILP was 68%, including 17% CR. Also, 80% showed progressive disease. Significantly higher response rates were shown for Kaposi sarcoma (KS) with 42% CR and 96% ORR (both p < 0.001), and significantly higher CR rates for angiosarcoma (AS, 45%, p < 0.001) and clear cell sarcoma (CCS, 31%, p = 0.049). ILP was followed by resection ≤ 6 months in 80% of the patients. The overall limb salvage rate was 88%, without significant differences among histological subgroups, but was significantly higher for ILP responders compared to non-responders (93% versus 76%, p < 0.001). CONCLUSION: ILP resulted in high response and LRS among all eSTS subtypes, however, with significant differences between subtypes with most promising results for KS, AS and CCS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaSoft Tissue NeoplasmsSarcoma, KaposiAdultHumansRetrospective StudiesChemotherapy, Cancer, Regional PerfusionMelphalanExtremitiesPerfusionTumor Necrosis Factor-alphaAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

ILPIsolated limb perfusionResponse evaluationSoft-tissue sarcoma

Substanzen

MelphalanTumor Necrosis Factor-alphaAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: s.reijers@nki.nl.
  • Department of Surgical Oncology, Royal Marsden Hospital, 203 Fulham Rd., SW3 6JJ London, UK. Electronic address: emma.davies@icr.ac.uk.
  • Department of Surgical Oncology, Erasmus Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands. Electronic address: d.grunhagen@erasmusmc.nl.
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milan, Italy. Electronic address: marco.fiore@istitutotumori.mi.it.
  • Department of Surgical Oncology, Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: charles.honore@gustaveroussy.fr.
  • Department of Surgery Oncology and Gastroenterology, University of Padova, Via VIII Febbraio, 2, 35122 Padua, Italy; Department of Surgical Oncology, Istituto Oncologico Veneto (IOV), Via Gattamelata, 64, 35128 Padua, I…

Zitieren

APA

Reijers, S. J. M., Davies, E., Grünhagen, D. J., Fiore, M., Honore, C., Rastrelli, M., Vassos, N., Podleska, L. E., Niethard, M., Jakob, J., Perhavec, A., Duarte, C., González, F., Deroose, J. P., Stas, M., Boecxstaens, V., Schrage, Y., Snow, H., Algarra, S. M., …, & van Houdt, W. J. (2023). Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.112949

Vancouver

Reijers SJM, Davies E, Grünhagen DJ, Fiore M, Honore C, Rastrelli M, et al. Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.112949

BibTeX
@article{Reijers2023,
  author = {Reijers, Sophie J M and Davies, Emma and Grünhagen, Dirk J and Fiore, Marco and Honore, Charles and Rastrelli, Marco and Vassos, Nikolaos and Podleska, Lars E and Niethard, Maya and Jakob, Jens and Perhavec, Andraz and Duarte, Carlos and González, Felipe and Deroose, Jan P and Stas, Marguerite and Boecxstaens, Veerle and Schrage, Yvonne and Snow, Hayden and Algarra, Salvador Martín and Said, Hector Martinez and Garcia-Ortega, Dorian Yarih and Martin, Karla and Mattsson, Jan and Djafarrian, Reza and Di Lorenzo, Giorgia and Colombo, Chiara and Gronchi, Alessandro and Matter, Maurice and Verhoef, Cornelis and Olofsson Bagge, Roger and Hohenberger, Peter and Hayes, Andrew J and van Houdt, Winan J},
  title = {Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.112949}
}
Kostenlos starten →